Rigel Pharmaceuticals, Inc. RIGL
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. It operates as a clinical-stage biopharmaceutical firm, specializing in targeted drugs within the therapeutic a…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees162
TickerRIGL
Statistics
Market Cap$616.5M
Revenue (TTM)$294.3M
Net Income$367.0M
Net Margin124.7%
EPS$19.48
P/E1.66
P/S1.98
P/B1.48
EV/EBITDA3.88
ROE174.1%
Dividend Yield—
Price$33.35
Data: Twelve Data · Revenue = mcap / P/S